StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
107
This month
1
This year
1
Publishing Date
2023 - 07 - 17
2
2023 - 03 - 14
3
2023 - 03 - 08
2
2023 - 01 - 06
2
2022 - 10 - 21
2
2022 - 03 - 11
2
2021 - 11 - 09
1
2021 - 11 - 04
1
2021 - 11 - 03
2
2021 - 11 - 02
1
2021 - 09 - 23
1
2021 - 09 - 20
2
2021 - 09 - 09
1
2021 - 09 - 08
2
2021 - 09 - 07
1
2021 - 09 - 02
1
2021 - 08 - 24
1
2021 - 08 - 12
1
2021 - 08 - 05
1
2021 - 07 - 28
1
2021 - 06 - 24
1
2021 - 06 - 21
1
2021 - 06 - 17
1
2021 - 06 - 16
1
2021 - 06 - 11
1
2021 - 06 - 10
1
2021 - 06 - 07
1
2021 - 05 - 25
1
2021 - 05 - 11
1
2021 - 05 - 03
1
2021 - 04 - 22
1
2021 - 03 - 05
1
2021 - 03 - 02
1
2021 - 02 - 25
1
2021 - 02 - 01
1
2021 - 01 - 29
1
2021 - 01 - 19
1
2021 - 01 - 08
1
2020 - 12 - 21
1
2020 - 12 - 15
1
2020 - 11 - 04
1
2020 - 10 - 30
1
2020 - 10 - 21
1
2020 - 10 - 14
1
2020 - 09 - 24
1
2020 - 09 - 14
1
2020 - 09 - 09
1
2020 - 09 - 03
1
2020 - 08 - 31
1
2020 - 07 - 28
1
2020 - 07 - 23
1
2020 - 06 - 25
1
2020 - 06 - 24
1
2020 - 04 - 30
1
2020 - 04 - 20
1
2020 - 04 - 03
1
2020 - 03 - 26
1
2020 - 03 - 24
1
2020 - 03 - 23
1
2020 - 03 - 03
1
Sector
Agriculture, forestry, fishing and hunting
1
Finance
2
Health services
3
Health technology
107
Manufacturing
1
N/a
1
Process industries
1
Transportation and warehousing
1
Tags
Acquire
1
Acquisition
1
Aesthetic
1
Agreement
3
Antiviral
2
Application
2
Approval
1
Audio
1
Bio-nc
1
Biotech-beach
1
Calendar of events
3
Ceo
1
Ces
1
Changes in company's own shares
1
Commercialization
3
Companies
1
Company announcement
7
Conference
12
Covid
4
Covid-19
4
Derm
1
Direct
2
Directors and officers
2
Drug
2
Earnings releases and operating results
1
Enroll
4
Events
2
Fda
7
Fda acceptance
1
Financial
6
Financial results
9
Ford
2
Group
1
Health
3
In vitro
1
Life science
2
Market
2
Molluscum
9
N/a
81
Nasdaq
3
Offering
10
Pdufa
2
Pharmaceuticals
2
Phase 3
10
Positive
4
Pre-clinical
2
Preclinical
2
Presentation
4
Press releases
5
Program
3
Psoriasis
2
Publication
3
Report
7
Results
23
Sb206
5
Therapeutics
5
Treatment
10
Trial
3
Update
6
Year
2
Entities
9 meters biopharma, inc.
1
Amyris, inc.
1
Appharvest, inc.
1
Aridis pharmaceuticals inc.
1
Chain bridge i
1
Chembio diagnostics, inc.
1
Eli lilly and company
1
Heritage commerce corp
1
Latamgrowth spac
1
Ligand pharmaceuticals incorporated
4
Nabriva therapeutics plc
1
Nasdaq, inc.
1
Novan, inc.
107
Nymox pharmaceutical corporation
1
Pfizer, inc.
1
Proterra inc
1
Syneos health, inc.
3
Trevena, inc.
1
Uta acquisition corp
1
Viewray, inc.
1
Yellow corporation
1
Symbols
AAPL
1198
ABB
1427
ABBV
1024
ABLZF
1166
ABT
1787
ACN
600
AMGN
742
ARVL
4294
AVGO
593
AZN
665
BDX
796
BMY
662
BNPQF
1764
BNPQY
1764
CSCO
897
DHR
785
ERIC
1612
F
641
FNCTF
7191
FRBA
598
GE
917
GLAXF
658
GOOG
1281
GOOGL
1280
GSK
884
HON
1787
HUBS
1400
IBM
655
INTC
955
IT
594
JNJ
4583
LLY
1709
LTUM
971
LYV
717
MDT
1285
MMM
938
MS
4286
MSFT
1201
MT
589
NOK
901
NOKBF
975
NVO
632
NVS
1241
NVSEF
1031
ORCL
1158
PCRFF
650
PCRFY
650
PFE
692
PHG
962
PPRUF
1128
PPRUY
1129
SAP
1477
SAPGF
1231
SNOW
796
SNY
4539
SNYNF
3597
TEVJF
631
TMO
1623
VZ
1213
XYF
676
Exchanges
Nasdaq
107
Nyse
1
Crawled Date
2023 - 07 - 17
2
2023 - 03 - 14
3
2023 - 03 - 08
2
2023 - 01 - 06
2
2022 - 10 - 21
2
2022 - 10 - 14
1
2022 - 09 - 15
1
2022 - 08 - 11
1
2022 - 08 - 04
1
2022 - 07 - 19
1
2022 - 07 - 13
1
2022 - 06 - 13
1
2022 - 06 - 09
1
2022 - 05 - 19
1
2022 - 05 - 16
1
2022 - 05 - 06
1
2022 - 04 - 20
1
2022 - 03 - 24
1
2022 - 03 - 14
1
2022 - 03 - 11
2
2022 - 02 - 22
1
2022 - 02 - 15
1
2022 - 01 - 14
1
2021 - 11 - 12
1
2021 - 11 - 10
1
2021 - 11 - 09
1
2021 - 11 - 04
1
2021 - 11 - 03
2
2021 - 11 - 02
1
2021 - 09 - 23
1
2021 - 09 - 20
2
2021 - 09 - 09
1
2021 - 09 - 08
2
2021 - 09 - 07
1
2021 - 09 - 02
1
2021 - 08 - 24
1
2021 - 08 - 12
1
2021 - 08 - 05
1
2021 - 07 - 28
1
2021 - 06 - 24
1
2021 - 06 - 21
1
2021 - 06 - 17
1
2021 - 06 - 16
1
2021 - 06 - 11
1
2021 - 06 - 10
1
2021 - 06 - 07
1
2021 - 05 - 25
1
2021 - 05 - 11
1
2021 - 05 - 03
1
2021 - 04 - 22
1
2021 - 03 - 05
1
2021 - 03 - 02
1
2021 - 02 - 25
1
2021 - 02 - 01
1
2021 - 01 - 29
1
2021 - 01 - 19
1
2021 - 01 - 08
1
2020 - 12 - 21
1
2020 - 12 - 15
1
2020 - 12 - 01
20
Crawled Time
03:00
1
11:00
6
12:00
6
12:15
2
12:20
3
12:30
1
13:00
17
13:06
1
13:15
6
13:20
11
13:30
2
14:00
8
14:01
3
14:03
2
14:05
1
14:20
2
14:30
2
15:20
1
16:00
1
20:00
5
21:00
3
21:06
1
22:13
20
23:00
2
Source
www.biospace.com
6
www.globenewswire.com
92
www.novan.com
6
www.prnewswire.com
3
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
NOVN
save search
Ligand Pharmaceuticals Announces Launch of Pelthos Therapeutics to Accelerate Commercialization of ZELSUVMI™
Published:
2024-04-03
(Crawled : 14:30)
- biospace.com/
LGND
|
$72.59
0.1%
0.1%
140K
|
Health Technology
|
-1.01%
|
O:
-0.83%
H:
3.14%
C:
2.93%
pharmaceuticals
commercialization
therapeutics
Delisting of Securities of Nymox Pharmaceutical Corporation; Aridis Pharmaceuticals Inc.; Novan, Inc.; ViewRay, Inc.; 9 Meters Biopharma, Inc.; Nabriva Therapeutics plc; UTA Acquisition Corporation; AppHarvest, Inc.; Yellow Corporation; Proterra Inc.; Amyris, Inc.; Chain Bridge I; LatAmGrowth SPAC; and SpringBig Holdings, Inc. from The Nasdaq Stock Market
Published:
2023-09-07
(Crawled : 20:00)
- globenewswire.com
AMRSQ
|
$0.0015
-95.0%
21K
|
Manufacturing
|
-91.11%
|
O:
-10.0%
H:
16.05%
C:
8.64%
VRAYQ
|
$0.0001
0.0%
600
|
Manufacturing
|
-99.99%
|
O:
6.84%
H:
13.6%
C:
-4.0%
NDAQ
|
$60.35
0.47%
0.46%
3.1M
|
Finance
|
16.82%
|
O:
0.0%
H:
0.19%
C:
-0.45%
ARDS
|
$0.0615
2.82%
410K
|
Health Technology
|
-31.03%
|
O:
0.0%
H:
13.45%
C:
-12.07%
nasdaq
acquisition
pharmaceuticals
therapeutics
proterra
market
Ligand Offers $15 Million to Acquire Assets of Novan, Inc.
Published:
2023-07-17
(Crawled : 14:20)
- biospace.com/
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-84.6%
|
O:
-63.13%
H:
2.09%
C:
-20.11%
LGND
|
$72.59
0.1%
0.1%
140K
|
Health Technology
|
6.81%
|
O:
0.94%
H:
1.74%
C:
0.39%
acquire
Novan Enters into Agreement to Sell Substantially All of its Assets, including Berdazimer Gel, 10.3% (SB206), and Files for Chapter 11 Protection
Published:
2023-07-17
(Crawled : 13:00)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-84.6%
|
O:
-63.13%
H:
2.09%
C:
-20.11%
LGND
|
$72.59
0.1%
0.1%
140K
|
Health Technology
|
6.81%
|
O:
0.94%
H:
1.74%
C:
0.39%
sb206
agreement
Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
Published:
2023-06-05
(Crawled : 13:00)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-91.67%
|
O:
2.65%
H:
4.31%
C:
-0.86%
update
meeting
Novan Focuses Strategic Direction and Announces Restructuring
Published:
2023-05-31
(Crawled : 20:00)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-93.08%
|
O:
-8.82%
H:
0.0%
C:
-9.68%
Novan Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published:
2023-05-15
(Crawled : 11:00)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-92.65%
|
O:
-6.25%
H:
1.58%
C:
-3.33%
update
financial
results
Novan to Report First Quarter 2023 Financial Results on May 15, 2023
Published:
2023-05-08
(Crawled : 13:20)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-91.75%
|
O:
-0.88%
H:
4.42%
C:
-1.77%
report
financial
results
Novan Announces Publication of Psoriasis Patient Data Demonstrating Need for Rapid Symptom Improvement¹
Published:
2023-04-27
(Crawled : 13:20)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-92.41%
|
O:
-1.61%
H:
4.1%
C:
0.82%
rapid
psoriasis
publication
Novan to Host Analyst and Investor Event: A Discussion of Molluscum’s Unmet Need with Pediatric Dermatologist Jeffrey Sugarman, MD, PhD
Published:
2023-04-20
(Crawled : 13:20)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-92.98%
|
O:
-2.24%
H:
3.05%
C:
1.53%
Novan Reports Full Year 2022 Financial Results and Provides Corporate Update
Published:
2023-03-30
(Crawled : 11:00)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-91.52%
|
O:
7.21%
H:
7.55%
C:
0.84%
year
update
financial
results
Novan to Report Full Year 2022 Financial Results on March 30, 2023
Published:
2023-03-23
(Crawled : 13:00)
- novan.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-92.41%
|
O:
0.81%
H:
0.0%
C:
-8.0%
report
year
financial
results
Novan Announces Closing of $6.0 Million Registered Direct Offering
Published:
2023-03-16
(Crawled : 21:00)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-91.67%
|
O:
0.0%
H:
0.88%
C:
-5.31%
direct
offering
Novan to Present at the Oppenheimer 33rd Annual Healthcare ConferencePresentation with live webcast today, March 14th at 10:40 AM ET
Published:
2023-03-14
(Crawled : 14:00)
- biospace.com/
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-92.09%
|
O:
-5.88%
H:
8.04%
C:
4.46%
Novan to Present at the Oppenheimer 33rd Annual Healthcare Conference
Published:
2023-03-14
(Crawled : 12:20)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-92.09%
|
O:
-5.88%
H:
8.04%
C:
4.46%
conference
Novan Announces $6.0 Million Registered Direct Offering
Published:
2023-03-14
(Crawled : 12:20)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-92.09%
|
O:
-5.88%
H:
8.04%
C:
4.46%
offering
direct
Novan Moves Forward with Unified Corporate Branding
Published:
2023-03-08
(Crawled : 14:00)
- novan.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-93.03%
|
O:
4.44%
H:
0.0%
C:
-4.26%
FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024
Published:
2023-03-08
(Crawled : 03:00)
- novan.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-93.03%
|
O:
4.44%
H:
0.0%
C:
-4.26%
molluscum
treatment
fda
pdufa
FDA Accepts Novan’s NDA for Berdazimer Gel, 10.3% for the Treatment of Molluscum Contagiosum with a PDUFA Goal Date of January 5, 2024
Published:
2023-03-07
(Crawled : 13:20)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-92.87%
|
O:
5.3%
H:
1.44%
C:
-2.88%
molluscum
treatment
fda
pdufa
Novan to Present at the Virtual Investor 2023 Companies to Watch Event
Published:
2023-01-18
(Crawled : 13:20)
- globenewswire.com
NOVN
|
$0.0941
-24.84%
-32.91%
7.2M
|
Health Technology
|
-92.76%
|
O:
0.77%
H:
5.14%
C:
-2.29%
companies
← Previous
1
2
3
4
5
6
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.